Nothing is as constant as change - here you will find all news about our product developments, news from our company and current information about in vitro diagnostics.
Reliably typing even more variants of the corona virus SARS-CoV-2! With the new differentiation kit ViroQ® SC2 Variant 2, even more deviations from the virus of origin can be reliably detected.
The new SARS Cov-2 rapid antigen test can identify persons infected with the Corona virus and, therefore, prevent further contagion. After only 15 minutes, the results can be taken directly on site - a laboratory is not necessary.
Innovation in virological infectiology: The new real-time rapid test ViroQ SARS-FluA/B-RSV. The new test reliably detectss with just one PCR run SARS-CoV-2, RS, Influenza A and B viruses.
With our new distribution partner Sysmex America, Inc. the PCR rapid test for the safe detection of SARS CoV-2 is now also available in the USA and Canada. FDA EUA certification has already been submitted.
BAG Diagnostics has developed a rapid test that transcribes and amplifies the RNA from SARS-CoV-2 to cDNA in a one-step PCR procedure. The kit is the first test to check whether there is enough cell material in the sample smear to produce a valid negative result.
For complete HLA typing with low to medium resolution, HISTO TYPE Rainbow is the fast and easy solution. Type the 11 most important HLA loci in a 96 PCR plate.
The new solution for the secondary determination of serologically discrete or doubtful Rhesus D antigens with suspected Weak D will be available from August 2019.
